ArticleForensic science, medicine, and pathology2026
Fumarate hydratase downregulation in myocardial tissue: a potential biomarker for death from mechanical asphyxia.
Article in Forensic science, medicine, and pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The authentication of death from mechanical asphyxia (DMA) remains a significant challenge in forensic pathology because of the lack of specific biomarkers. The present study identified fumarate hydratase (FH), a key tricarboxylic acid (TCA) cycle enzyme, as a potential biomarker associated with DMA and investigated its regulatory mechanism in the context of acute severe hypoxia. Western blot analysis of 87 human myocardial samples revealed that FH protein expression was significantly downregulated in DMA cases than in controls (hemorrhagic shock, brain injury, and other causes). These findings were independently validated by immunohistochemistry (IHC) in a separate cohort of 118 human samples. The diagnostic performance of myocardial FH, evaluated by receiver operating characteristic curve analysis, yielded an area under the curve of 0.8561, with 84.38% sensitivity and 70.93% specificity. In vitro experiments using AC16 cardiomyocytes revealed that hypoxia led to decreased FH expression at both the mRNA and protein levels, and this effect was reversed by the N-acetylcysteine antioxidant. FH downregulation resulted in significant accumulation of its substrate, fumarate, in human DMA myocardium, hypoxic cells, and culture medium. This subsequent accumulation of fumarate triggered the activation of the cytoprotective KEAP1-NRF2 pathway, as evidenced by NRF2 nuclear translocation and the upregulation of downstream antioxidant genes. Collectively, the present results support myocardial FH downregulation as a promising adjunctive biomarker associated with DMA and reveal a novel hypoxia-FH-fumarate-NRF2 axis, providing crucial insights into cellular responses to fatal hypoxic injury. KEY POINTS: • FH expression is significantly reduced in myocardial tissue from mechanical asphyxia cases. • FH immunohistochemistry shows potential utility for the postmortem identification of mechanical asphyxia. • Hypoxia-induced FH suppression leads to fumarate accumulation in cardiomyocytes. • Fumarate accumulation activates the KEAP1-NRF2 antioxidant pathway.
Indexed as
Identifiers
42579241What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.